| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/08/2013 | CN103087166A Potassium hydrogen pump protein, and coding gene and applications thereof |
| 05/08/2013 | CN103087165A Sodium hydrogen pump protein, and coding gene and applications thereof |
| 05/08/2013 | CN103087164A Sodium hydrogen pump protein, and coding gene and applications thereof |
| 05/08/2013 | CN103087163A K<+>/H<+>antiporter protein, its coding gene, and applications of protein and coding gene |
| 05/08/2013 | CN103087162A Na<+>/H<+>antiporter protein, its coding gene, and applications of protein and gene |
| 05/08/2013 | CN103087161A Novel method for purifying polyethylene (PE) recombinant toxin |
| 05/08/2013 | CN103087160A Flagellum motor protein, coding gene thereof, and applications thereof |
| 05/08/2013 | CN103087159A Sodium hydrogen pump protein, and coding gene and applications thereof |
| 05/08/2013 | CN103087158A Flagellum motor protein, and coding gene and application thereof |
| 05/08/2013 | CN103087157A Betaine transport protein, coding gene thereof, and applications of betaine transport protein and coding gene |
| 05/08/2013 | CN103087156A Foot and mouth disease virus (FMDV) antigen polypeptide and vaccine |
| 05/08/2013 | CN103087155A Rabies virus vaccine enhancin, gene for coding enhancin and application of enhancin |
| 05/08/2013 | CN103087154A Polypeptide for preparing monoclonal antibody for detecting acetylcholin esterase and application of polypeptide |
| 05/08/2013 | CN103087153A New neovessel inhibition small peptides and applications thereof |
| 05/08/2013 | CN102690831B El-b3a gene in soybean growth period and coding protein thereof |
| 05/08/2013 | CN102660568B A method for preparing recombinant thymulin alpha 1 |
| 05/08/2013 | CN102643832B Soybean growth period E1 gene and encoding protein of soybean growth period E1 gene |
| 05/08/2013 | CN102604966B NF-YA6 protein and application of coding gene of NF-YA6 protein in culture of plant with improved fatty acid content |
| 05/08/2013 | CN102475890B Acceptor protein, and coding gene and application thereof |
| 05/08/2013 | CN102382185B Plant aquaporin and application of encoding gene thereof |
| 05/08/2013 | CN102321162B GbRPS1 gene for resisting plant fusarium wilt and verticillium wilt and application thereof |
| 05/08/2013 | CN102304178B Preparation method and application of African clawed toad antitumor polypeptide |
| 05/08/2013 | CN101928342B High-purity menopausal gonadotropin as well as preparation method and application thereof |
| 05/08/2013 | CN101906153B Extraction process for preparing nisin |
| 05/08/2013 | CN101899102B Method for separating high purity phycocyanin from spirulina |
| 05/08/2013 | CN101821286B Process for producing mature recombinant mite group i allergen |
| 05/08/2013 | CN101743253B Crystal structures of neuropilin fragments and neuropilin-antibody complexes |
| 05/08/2013 | CN101616930B Method of purification of hydrophobic proteins |
| 05/08/2013 | CN101533024B Application of Yersinia pestis Caf1M protein |
| 05/08/2013 | CN101469020B Rare minnow beta type estrogen receptor and use thereof |
| 05/08/2013 | CN101356274B Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870 |
| 05/08/2013 | CN101254300B Intestinotrophic glucagon-like peptide-2 analogs |
| 05/08/2013 | CN101128213B Promoter of regeneration of pancreatic beta cell, and promoter of insulin production in pancreatic beta cell |
| 05/08/2013 | CN101115766B Codon-optimized HPV16LI for salmonella vaccine strains against human papillomavirus type 16 |
| 05/07/2013 | US8436148 Antibodies against interleukin-18 binding protein, their preparation and use |
| 05/07/2013 | US8436146 Therapeutic use of anti-CS1 antibodies |
| 05/07/2013 | US8436143 T1R taste receptors and genes encoding same |
| 05/07/2013 | US8436139 Apo-lipoprotein B fragment for use in prevention and treatment of cardiovascular and ischemic disorders |
| 05/07/2013 | US8436021 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity |
| 05/07/2013 | US8435953 Sustained release composition containing SDF-1 |
| 05/07/2013 | US8435780 Class II human histone deacetylases, and uses related thereto |
| 05/07/2013 | US8435762 Chimeric ligand-gated ion channels and methods of use thereof |
| 05/07/2013 | US8435543 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 05/07/2013 | US8435540 Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in VIVO |
| 05/07/2013 | US8435538 Anti-atheroma vaccine |
| 05/07/2013 | US8435535 Fusion proteins of HIV regulatory/accessory proteins |
| 05/07/2013 | US8435534 Cancer immunotherapy |
| 05/07/2013 | US8435525 FGF modulation of in vivo antibody production and humoral immunity |
| 05/07/2013 | US8435495 Characterization of granulocytic Ehrlichia and methods of use |
| 05/07/2013 | CA2789369C Method, tools and kits for the detection of members of the staphylococcus genus |
| 05/07/2013 | CA2644130C Polynucleotide encoding a maize herbicide resistance gene and methods for use |
| 05/07/2013 | CA2572555C Fusion protein of porcine reproductive and respiratory syndrome virus as prrs vaccine |
| 05/07/2013 | CA2560185C Novel assay for the separation and quantification of hemagglutinin antigens |
| 05/07/2013 | CA2516651C Methods of screening for trpm5 modulators |
| 05/07/2013 | CA2475073C Hypoallergenic polypeptides based on fish parvalbumin |
| 05/07/2013 | CA2467053C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/07/2013 | CA2383982C Transgenic animal expressing a multiple mutated form of presenilin 1 |
| 05/07/2013 | CA2360347C Improved expression of hiv polypeptides and production of virus-like particles |
| 05/02/2013 | WO2013063572A1 Ultra-concentrated rapid-acting insulin analogue formulations |
| 05/02/2013 | WO2013063556A1 Humanized il-6 and il-6 receptor |
| 05/02/2013 | WO2013063528A2 Isoprene synthase variants with improved solubility for production of isoprene |
| 05/02/2013 | WO2013063361A1 Genetically modified t cell receptor mice |
| 05/02/2013 | WO2013063340A1 Transgenic mice expressing chimeric major histocompatibility complex (mhc) class ii molecules |
| 05/02/2013 | WO2013063248A1 Vaccines and methods for creating a vaccine for inducing immunity to all dengue virus serotypes |
| 05/02/2013 | WO2013063246A1 Engineered subcellular compartments |
| 05/02/2013 | WO2013062444A1 Peptide azemiopsin selectively interacting with nicotinic acetylcholine receptors of muscle type |
| 05/02/2013 | WO2013062327A2 Ａｔｐｇ4 protein having productivity increase function, anti-aging function, stress resistance function of plants, genes thereof, and uses thereof |
| 05/02/2013 | WO2013062069A1 Geminivirus replication inhibitor |
| 05/02/2013 | WO2013061818A1 Novel peptide complex and hybrid complex thereof, and use of said hybrid complex |
| 05/02/2013 | WO2013061487A1 METHOD FOR CAUSING EXPRESSION OF MOUSE OLFACTORY RECEPTOR Olfr15 ON CELL MEMBRANE |
| 05/02/2013 | WO2013061273A1 A modified effector cell (or chimeric receptor) for treating disialoganglioside gd2 -expressing neoplasia |
| 05/02/2013 | WO2013061106A1 Modified peptide toxins |
| 05/02/2013 | WO2013061091A2 Cystic fibrosis treatment |
| 05/02/2013 | WO2013061056A1 Vaccine |
| 05/02/2013 | WO2013060995A1 Method for preparing human factor h |
| 05/02/2013 | WO2013060864A1 Chimeric molecule involving oligomerized fasl extracellular domain |
| 05/02/2013 | WO2013060328A1 Ikb based immunotherapy |
| 05/02/2013 | WO2013060303A1 Polypeptides inhibiting neovascularization and uses thereof |
| 05/02/2013 | WO2013060293A1 Polypeptides having xylanase activity and polynucleotides encoding same |
| 05/02/2013 | WO2013060282A1 Method and kit for enriching and purifying stem cells, and uses thereof |
| 05/02/2013 | WO2013060020A1 Novel small peptide capable of inhibiting new vessels and application thereof |
| 05/02/2013 | WO2013059884A1 A gene and mutations thereof associated with seizure and movement disorders |
| 05/02/2013 | WO2013032999A3 Polydnavirus vectors |
| 05/02/2013 | WO2013014134A3 Polyoma virus jc peptides and proteins in vaccination and diagnostic applications |
| 05/02/2013 | WO2013011011A3 Method of reversibly staining a target cell |
| 05/02/2013 | US20130111633 Plants and seeds with altered storage compound levels, related constructs and methods involving genes encoding proteins with similarity to bacterial 2,4-dihydroxy-hept-2-ene-1,7-dioic acid class ii-like aldolase proteins |
| 05/02/2013 | US20130111613 Colon disease targets and uses thereof |
| 05/02/2013 | US20130109847 Detection or quantification of desirable target molecules, novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes |
| 05/02/2013 | US20130109842 Amino acid sequences of nanobodies directed against p19 subunit of the heterodimeric cytokine il-23 |
| 05/02/2013 | US20130109838 Method of altering the binding specificity of plasma proteins by oxidation-reduction |
| 05/02/2013 | US20130109837 Methods of making a diagnostic composition and compositions therefrom |
| 05/02/2013 | US20130109836 Silk fibroin porous material and method for producing same |
| 05/02/2013 | US20130109645 Adenosine receptor agonists for the treatment and prevention of vascular or joint capsule calcification disorders |
| 05/02/2013 | US20130109629 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer |
| 05/02/2013 | US20130109627 Alkylated sp-c peptoid compounds and related surfactant compositions |
| 05/02/2013 | US20130109624 Novel neurotrophic factors |
| 05/02/2013 | US20130109623 G-csf and water-soluble polymer conjugate |
| 05/02/2013 | US20130109619 Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling |
| 05/02/2013 | US20130109616 Antimicrobial peptides |
| 05/02/2013 | US20130109614 Antagonists for diseases induced by cells with high-affinity elr-cxc chemokine receptor proteins |